AbbVie Germany and EMBL’s Microbiome Summit 2023 AbbVie Germany and EMBL’s Microbiome Summit 2023 February 15, 2024 General Read more
ProteomicsML: empowering proteomics research with machine learning ProteomicsML: empowering proteomics research with machine learning January 30, 2024 General Read more
Using Artificial Intelligence to Discover Therapeutic Antibodies Using Artificial Intelligence to Discover Therapeutic Antibodies December 19, 2023 General Read more
AI in biology and health: opportunities and challenges AI in biology and health: opportunities and challenges October 27, 2023 General Read more
Revealing the secrets of protein evolution using the AlphaFold database Revealing the secrets of protein evolution using the AlphaFold database September 18, 2023 General Read more
Novel algorithm able to detect mutations in single-cell sequencing data sets Novel algorithm able to detect mutations in single-cell sequencing data sets August 11, 2023 General Read more
EMBL and ZEISS enter long-term strategic partnership EMBL and ZEISS enter long-term strategic partnership July 7, 2023 General Read more
David Hulcoop appointed as Open Targets Director David Hulcoop appointed as Open Targets Director July 5, 2023 General Read more
